According to the latest market research by the custom market insights, the global Point-of-Care Glucose Testing Market is projected to grow at a CAGR of 4.5% from 2025 to 2034. The market size is expected to reach USD 3,670.9 million in 2025 and is anticipated to reach USD 5,455.3 million by 2034.
Key factors driving this growth include the increasing geriatric population, the ability of point-of-care (POC) testing to deliver instant and timely results, and the rising adoption of Electronic Medical Records (EMRs).
Download FREE our Comprehensive Market Research Report and Stay Ahead of the Competition @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=54643
The surge in diabetes cases, advancements in glucose monitoring technology, and growing awareness of POC glucose testing are further fueling market expansion. With the introduction of needle-free glucose monitoring devices, many companies are now offering painless diabetes care solutions.
POC glucose testing provides patients with the convenience of rapid glucose readings without the need for laboratory visits, enabling them to monitor their levels at home or other non-clinical settings.
In Asian nations, the market is expected to see significant growth due to increasing diabetes awareness, limited healthcare facilities, and a shortage of healthcare professionals. These factors present an opportunity to reduce healthcare costs while enhancing care quality.
Report Scope –
|
Feature of the Report |
Details |
|
Market Size in 2025 |
USD 3,670.9 Million |
|
Projected Market Size in 2034 |
USD 5,455.3 Million |
|
Market Size in 2024 |
USD 3,512.8 Million |
|
CAGR Growth Rate |
4.5% CAGR |
|
Base Year |
2024 |
|
Forecast Period |
2025-2034 |
|
Key Segment |
By Product, Technology, Application, End Users and Region |
|
Report Coverage |
Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
Get Your Personalized Report! Avail FREE Customization to Focus on the Insights that Matter Most to You - https://www.custommarketinsights.com/request-for-customization/?reportid=54643
Point-of-Care Glucose Testing Market: Key Trends and Opportunistic Frontiers
- Technological Advancements: Ongoing advancements in POC glucose testing technologies are making testing processes more accurate, convenient, and efficient. Enhanced features such as improved sensors and faster processing times have positively impacted the adoption of these technologies.
- Integration in Healthcare Settings: The integration of glucose testing in point-of-care environments such as doctor’s offices, clinics, and pharmacies allows for rapid test results and immediate treatment adjustments, significantly improving patient care.
- Telemedicine and Remote Monitoring: The rise of telemedicine and remote healthcare services has opened up opportunities for POC glucose testing. Patients can seamlessly share their glucose data with healthcare providers for virtual consultations and tailored treatment plans.
Regional Analysis of the Point-of-Care Glucose Testing Market
- North America: North America is poised to dominate the market, driven by the presence of prominent key players such as Abbott, Nova Medical, and Prodigy Diabetes Care, LLC. Additionally, initiatives by government and not-for-profit organizations to increase awareness of advanced glucose meters and heightened government spending on diabetes management are key growth factors.
- Asia Pacific: The Asia Pacific region is projected to witness significant growth due to a constantly expanding healthcare infrastructure and a rising prevalence of diabetes. The increased adoption of smaller POC glucose testing variants and the hesitancy to visit hospitals or clinics have boosted demand in the region.
- Europe and Latin America: Steady market growth is expected in these regions, driven by enhanced healthcare systems and increasing adoption of advanced diagnostic technologies.
- Middle East & Africa: The adoption of POC glucose diagnostics is anticipated to grow due to increasing healthcare investments and the demand for quick and accurate results in critical care environments.
Click Here to Access a Free Sample Report of the Global Point-of-Care Glucose Testing Market - https://www.custommarketinsights.com/request-for-free-sample/?reportid=54643
Competitive Landscape
The Point-of-Care Glucose Testing Market is highly fragmented with the presence of numerous large, small, and medium-scale vendors. Key players are focusing on multiple growth strategies such as new product launches, expansions, collaborations, partnerships, and acquisitions. Leading companies in the market include:
- Abbott Laboratories
- Hoffmann-La Roche Ltd.
- Ascensia Diabetes Care Holdings AG
- Dexcom, Inc.
- Medtronic plc
- LifeScan, Inc. (A Johnson & Johnson Company)
- Becton, Dickinson and Company
- Acon Laboratories, Inc.
- Nova Biomedical Corporation
- ARKRAY, Inc.
- Trividia Health, Inc.
- PTS Diagnostics
- Nipro Diagnostics, Inc.
- Ypsomed Holding AG
- Sanofi S.A.
- Others
Key Developments in the Point-of-Care Glucose Testing Market
2024: Trinity Biotech (TRIB) acquired biosensor and CGM assets from Waveform Technologies for $12.5M and 9M ADSs, strengthening its diabetes care market position.
2023: Canada approved Dexcom’s G7 CGM system for type-1 diabetes, enhancing real-time glucose monitoring.
2022: Roche launched the cobas pulse system, a digital health-integrated blood glucose management solution for improved patient care.
Email Directly Here with Detail Information: support@custommarketinsights.com
Product Portfolio and Market Segments
By Product Type:
- Freestyle Lite
- Accu-Chek Inform II
- StatStrip
- Onetouch Verio Flex
- Accu-Check Aviva Meter
- True Metrix
- i-STAT
- Other Product Types
By End User:
- Professional Diagnostic Centres
- Hospitals and Clinics
- Home Care Settings
- Research Labs
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
More Related Reports by Custom Market Insights –
US Diabetes Devices Market: Valued at USD 6.8B in 2024, projected to reach USD 19.8B by 2033 (CAGR 7.3%).
US Fitness Tracker Market: Valued at USD 14.8B in 2024, expected to hit USD 35.8B by 2033 (CAGR 15.3%).
Global Non-Invasive Blood Glucose Monitoring Devices Market: Estimated at USD 25M in 2022, reaching USD 169.33M by 2032 (CAGR 23%).
Global
Digital Health Market:
Valued at USD 181.6B in 2021, projected to grow to USD 810.12B by 2030 (CAGR
17.5%).
About Custom Market Insights:
Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains.
CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey.
Contact Us:
Joel John
Custom Market Insights
1333, 701 Tillery Street Unit 12,
Austin, TX, Travis, US, 78702
USA: +1 801-639-9061
India: +91 20 46022736
Email: support@custommarketinsights.com
Web: https://www.custommarketinsights.com/
Follow Us: LinkedIn| Twitter| Facebook | YouTube
You can place an order or ask any questions, please feel free to contact at
Email: support@custommarketinsights.com
| +1 801-639-9061
